Biohaven Pharmaceutical Holding Company Ltd (BHVN)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track Share on 𝕏

Stock chart

Ticker: BHVN Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale

Past 90 days

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Total value
2020-06-17	2020-06-15	PS Planned sale	Doogan Declan Non-Executive Director	11,164 -1.5% 65.62 732,560 USD	11,164 -1.5%	65.62	732,560 USD
2020-06-12	2020-06-12	PS Planned sale	Stock Elyse Chief Medical Officer Officer	11,390 -86.1% 65.80 749,497 USD	11,390 -86.1%	65.80	749,497 USD
2020-06-12	2020-06-12	PS Planned sale	Stock Elyse Chief Medical Officer Officer	15,925 -54.6% 64.89 1,033,348 USD	15,925 -54.6%	64.89	1,033,348 USD
2020-06-12	2020-06-12	PS Planned sale	Stock Elyse Chief Medical Officer Officer	5,300 -15.4% 64.05 339,448 USD	5,300 -15.4%	64.05	339,448 USD
2020-06-12	2020-06-12	PS Planned sale	Stock Elyse Chief Medical Officer Officer	4,351 -11.2% 63.02 274,209 USD	4,351 -11.2%	63.02	274,209 USD
2020-06-12	2020-06-12	PS Planned sale	Doogan Declan Non-Executive Director	25,914 -3.3% 65.78 1,704,750 USD	25,914 -3.3%	65.78	1,704,750 USD
2020-06-12	2020-06-12	PS Planned sale	Doogan Declan Non-Executive Director	28,086 -3.4% 64.79 1,819,684 USD	28,086 -3.4%	64.79	1,819,684 USD
2020-06-12	2020-06-12	PS Planned sale	Doogan Declan Non-Executive Director	18,400 -2.2% 63.90 1,175,767 USD	18,400 -2.2%	63.90	1,175,767 USD
2020-06-12	2020-06-12	PS Planned sale	Doogan Declan Non-Executive Director	7,600 -0.9% 62.93 478,252 USD	7,600 -0.9%	62.93	478,252 USD
2020-06-12	2020-06-11	PS Planned sale	Engelhart James Chief Financial Officer Officer	2,452 -35.2% 64.85 159,015 USD	2,452 -35.2%	64.85	159,015 USD
2020-06-12	2020-06-11	PS Planned sale	Engelhart James Chief Financial Officer Officer	6,501 -48.2% 64.31 418,058 USD	6,501 -48.2%	64.31	418,058 USD
2020-06-12	2020-06-11	PS Planned sale	Engelhart James Chief Financial Officer Officer	4,847 -26.5% 63.19 306,286 USD	4,847 -26.5%	63.19	306,286 USD
2020-06-12	2020-06-11	PS Planned sale	Engelhart James Chief Financial Officer Officer	5,972 -24.6% 62.07 370,698 USD	5,972 -24.6%	62.07	370,698 USD
2020-06-12	2020-06-11	PS Planned sale	Doogan Declan Non-Executive Director	25,039 -2.9% 64.57 1,616,873 USD	25,039 -2.9%	64.57	1,616,873 USD
2020-06-12	2020-06-11	PS Planned sale	Doogan Declan Non-Executive Director	18,474 -2.1% 63.79 1,178,530 USD	18,474 -2.1%	63.79	1,178,530 USD
2020-06-12	2020-06-11	PS Planned sale	Doogan Declan Non-Executive Director	20,043 -2.2% 62.78 1,258,207 USD	20,043 -2.2%	62.78	1,258,207 USD
2020-06-12	2020-06-11	PS Planned sale	Doogan Declan Non-Executive Director	16,444 -1.8% 61.97 1,018,989 USD	16,444 -1.8%	61.97	1,018,989 USD
2020-06-12	2020-06-10	PS Planned sale	Engelhart James Chief Financial Officer Officer	300 -6.2% 68.07 20,420 USD	300 -6.2%	68.07	20,420 USD
2020-06-12	2020-06-10	PS Planned sale	Engelhart James Chief Financial Officer Officer	24,832 -83.7% 67.53 1,676,989 USD	24,832 -83.7%	67.53	1,676,989 USD
2020-06-12	2020-06-10	PS Planned sale	Engelhart James Chief Financial Officer Officer	28,821 -49.3% 66.66 1,921,136 USD	28,821 -49.3%	66.66	1,921,136 USD
2020-06-12	2020-06-10	PS Planned sale	Tilton John Chief Commercial Officer Officer	2,467 -76.2% 69.40 171,202 USD	2,467 -76.2%	69.40	171,202 USD
2020-06-12	2020-06-10	PS Planned sale	Tilton John Chief Commercial Officer Officer	5,331 -62.2% 68.57 365,528 USD	5,331 -62.2%	68.57	365,528 USD
2020-06-12	2020-06-10	PS Planned sale	Tilton John Chief Commercial Officer Officer	22,838 -72.7% 67.53 1,542,234 USD	22,838 -72.7%	67.53	1,542,234 USD
2020-06-12	2020-06-10	PS Planned sale	Tilton John Chief Commercial Officer Officer	21,364 -40.5% 66.70 1,425,036 USD	21,364 -40.5%	66.70	1,425,036 USD
2020-06-10	2020-06-08	PS Planned sale	Gentile Kimberly SVP, Clinical Operations Officer	600 -14.2% 70.05 42,027 USD	600 -14.2%	70.05	42,027 USD
2020-04-08	2020-04-07	S Sale	CHILDS JOHN W	14,734 -0.6% 33.26 490,119 USD	14,734 -0.6%	33.26	490,119 USD
2020-04-08	2020-04-07	S Sale	CHILDS JOHN W	93,268 -3.6% 32.92 3,070,131 USD	93,268 -3.6%	32.92	3,070,131 USD
2020-04-08	2020-04-07	S Sale	CHILDS JOHN W	10,908 -0.4% 31.55 344,196 USD	10,908 -0.4%	31.55	344,196 USD
2020-04-08	2020-04-07	S Sale	CHILDS JOHN W	81,090 -3.0% 30.54 2,476,586 USD	81,090 -3.0%	30.54	2,476,586 USD
2020-04-08	2020-04-06	S Sale	CHILDS JOHN W	5,341 -0.2% 31.76 169,627 USD	5,341 -0.2%	31.76	169,627 USD
2020-04-08	2020-04-06	S Sale	CHILDS JOHN W	144,659 -5.1% 31.23 4,517,310 USD	144,659 -5.1%	31.23	4,517,310 USD
2020-01-24	2020-01-22	PS Planned sale	AGUIAR ERIC	150 -10.7% 58.86 8,829 USD	150 -10.7%	58.86	8,829 USD
2020-01-24	2020-01-22	PS Planned sale	AGUIAR ERIC	200 -12.5% 58.00 11,599 USD	200 -12.5%	58.00	11,599 USD
2020-01-24	2020-01-22	PS Planned sale	AGUIAR ERIC	671 -29.5% 56.99 38,243 USD	671 -29.5%	56.99	38,243 USD
2020-01-24	2020-01-22	PS Planned sale	AGUIAR ERIC	500 -18.0% 55.99 27,996 USD	500 -18.0%	55.99	27,996 USD
2020-01-24	2020-01-22	PS Planned sale	AGUIAR ERIC	500 -15.3% 54.97 27,486 USD	500 -15.3%	54.97	27,486 USD
2020-01-10	2020-01-09	S Sale	AGUIAR ERIC	30,000 -100.0% 56.39 1,691,700 USD	30,000 -100.0%	56.39	1,691,700 USD
2019-12-31	2019-12-30	PS Planned sale	Berman Robert Special Projects & Med Ovrsght	300 -46.8% 55.97 16,791 USD	300 -46.8%	55.97	16,791 USD
2019-12-31	2019-12-30	PS Planned sale	Berman Robert Special Projects & Med Ovrsght	3,488 -84.5% 54.89 191,462 USD	3,488 -84.5%	54.89	191,462 USD
2019-12-31	2019-12-30	PS Planned sale	Berman Robert Special Projects & Med Ovrsght	53,762 -92.9% 53.43 2,872,450 USD	53,762 -92.9%	53.43	2,872,450 USD
2019-12-31	2019-12-30	PS Planned sale	Berman Robert Special Projects & Med Ovrsght	67,450 -53.8% 52.95 3,571,349 USD	67,450 -53.8%	52.95	3,571,349 USD
2019-12-18	2019-12-16	PS Planned sale	AGUIAR ERIC Non-Executive Director	3,537 -100.0% 55.13 194,985 USD	3,537 -100.0%	55.13	194,985 USD
2019-12-11	2019-12-09	PS Planned sale	AGUIAR ERIC Non-Executive Director	4,072 -100.0% 55.11 224,411 USD	4,072 -100.0%	55.11	224,411 USD
2019-11-22	2019-11-22	PS Planned sale	GREGORY JULIA P Non-Executive Director	12,000 -100.0% 54.75 656,957 USD	12,000 -100.0%	54.75	656,957 USD
2019-11-22	2019-11-22	PS Planned sale	AGUIAR ERIC Non-Executive Director	1,250 -100.0% 55.24 69,050 USD	1,250 -100.0%	55.24	69,050 USD
2019-11-22	2019-11-21	PS Planned sale	Gentile Kimberly SVP, Clinical Operations Officer	21,065 -100.0% 53.04 1,117,205 USD	21,065 -100.0%	53.04	1,117,205 USD
2019-11-22	2019-11-20	PS Planned sale	AGUIAR ERIC Non-Executive Director	6,729 -100.0% 52.20 351,234 USD	6,729 -100.0%	52.20	351,234 USD
2019-11-22	2019-11-20	PS Planned sale	Gentile Kimberly SVP, Clinical Operations Officer	3,935 -100.0% 53.03 208,665 USD	3,935 -100.0%	53.03	208,665 USD
2019-10-25	2019-10-18	PS Planned sale	Stock Elyse Chief Medical Officer	17,700 -100.0% 45.07 797,750 USD	17,700 -100.0%	45.07	797,750 USD
2019-10-17	2019-10-15	PS Planned sale	Stock Elyse Chief Medical Officer	800 -100.0% 45.01 36,008 USD	800 -100.0%	45.01	36,008 USD
2019-09-13	2019-09-11	PS Planned sale	AGUIAR ERIC	10,000 -100.0% 45.00 450,000 USD	10,000 -100.0%	45.00	450,000 USD
2019-08-21	2019-08-20	B Purchase	Bailey Gregory Non-Executive Director	5,000 +0.2% 37.65 188,250 USD	5,000 +0.2%	37.65	188,250 USD
2019-06-28	2019-06-27	B Purchase	Engelhart James Chief Financial Officer	2,500 +inf% 43.05 107,625 USD	2,500 +inf%	43.05	107,625 USD
2019-06-28	2019-06-27	B Purchase	Berman Robert Chief Medical Officer	2,500 +1.1% 42.30 105,750 USD	2,500 +1.1%	42.30	105,750 USD
2019-06-26	2019-06-26	B Purchase	Coric Vlad Chief Executive Officer Executive Director	5,000 +35.4% 40.22 201,100 USD	5,000 +35.4%	40.22	201,100 USD
2019-06-26	2019-06-26	B Purchase	CHILDS JOHN W	10,000 +inf% 40.37 403,700 USD	10,000 +inf%	40.37	403,700 USD
2019-04-16	2019-04-16	PS Planned sale	Doogan Declan	50,000 -5.1% 61.92 3,096,000 USD	50,000 -5.1%	61.92	3,096,000 USD
2019-04-16	2019-04-12	PS Planned sale	Doogan Declan	38,825 -3.8% 53.92 2,093,444 USD	38,825 -3.8%	53.92	2,093,444 USD
2019-03-26	2019-03-26	PS Planned sale	Doogan Declan	5,824 -0.6% 53.72 312,865 USD	5,824 -0.6%	53.72	312,865 USD
2019-03-26	2019-03-22	PS Planned sale	Doogan Declan	5,351 -0.5% 53.66 287,135 USD	5,351 -0.5%	53.66	287,135 USD
2019-03-14	2019-03-14	PS Planned sale	Coric Vlad Chief Executive Officer Executive Director	15,783 -3.5% 50.03 789,623 USD	15,783 -3.5%	50.03	789,623 USD
2019-03-14	2019-03-14	PS Planned sale	Coric Vlad Chief Executive Officer Executive Director	16,110 -3.3% 50.02 805,822 USD	16,110 -3.3%	50.02	805,822 USD
2019-03-14	2019-03-13	PS Planned sale	Coric Vlad Chief Executive Officer Executive Director	8,262 -1.8% 50.02 413,265 USD	8,262 -1.8%	50.02	413,265 USD
2019-03-14	2019-03-13	PS Planned sale	Coric Vlad Chief Executive Officer Executive Director	7,883 -1.6% 50.02 394,308 USD	7,883 -1.6%	50.02	394,308 USD
2019-03-14	2019-03-12	PS Planned sale	Coric Vlad Chief Executive Officer Executive Director	25,955 -5.3% 50.15 1,301,643 USD	25,955 -5.3%	50.15	1,301,643 USD
2019-03-14	2019-03-12	PS Planned sale	Coric Vlad Chief Executive Officer Executive Director	26,007 -5.0% 50.15 1,304,251 USD	26,007 -5.0%	50.15	1,304,251 USD
2019-03-14	2019-03-12	PS Planned sale	Tilton John Chief Commercial Officer Officer	10,000 -100.0% 50.11 501,100 USD	10,000 -100.0%	50.11	501,100 USD
2019-03-01	2019-03-01	PS Planned sale	Doogan Declan Non-Executive Director	50,000 -4.6% 47.19 2,359,500 USD	50,000 -4.6%	47.19	2,359,500 USD
2019-03-01	2019-03-01	PS Planned sale	Doogan Declan Non-Executive Director	595 -0.1% 45.41 27,019 USD	595 -0.1%	45.41	27,019 USD
2019-03-01	2019-02-27	PS Planned sale	Doogan Declan Non-Executive Director	23,384 -2.1% 45.71 1,068,883 USD	23,384 -2.1%	45.71	1,068,883 USD
2019-03-01	2019-02-27	PS Planned sale	Doogan Declan Non-Executive Director	1,900 -0.5% 45.86 87,134 USD	1,900 -0.5%	45.86	87,134 USD
2019-03-01	2019-02-27	PS Planned sale	Doogan Declan Non-Executive Director	18,270 -4.6% 45.25 826,718 USD	18,270 -4.6%	45.25	826,718 USD
2019-03-01	2019-02-27	PS Planned sale	Doogan Declan Non-Executive Director	6,875 -1.7% 44.17 303,669 USD	6,875 -1.7%	44.17	303,669 USD
2019-02-26	2019-02-26	PS Planned sale	Doogan Declan Non-Executive Director	100 -0.0% 44.81 4,481 USD	100 -0.0%	44.81	4,481 USD
2019-02-26	2019-02-26	PS Planned sale	Doogan Declan Non-Executive Director	20,796 -4.9% 44.31 921,471 USD	20,796 -4.9%	44.31	921,471 USD